Antagonism of oestrogen action in human breast and endometrial cells in vitro: potential novel antitumour agents
β Scribed by Mark E. Nuttall; Israil Pendrak; John G. Emery; Daniel P. Nadeau; Paul W. Fisher; Thema A. Nicholson; Yuan Zhu; Larry J. Suva; William D. Kingsbury; Maxine Gowen
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 160 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Benzyl salicylate, benzyl benzoate and butylphenylmethylpropional (Lilial) are added to bodycare cosmetics used around the human breast. We report here that all three compounds possess oestrogenic activity in assays using the oestrogenβresponsive MCF7 human breast cancer cell line. At 3
## Abstract The mechanism of action of ZR2002, a chimeric amino quinazoline designed to possess mixed EGFR tyrosine kinase (TK) inhibitory and DNA targeting properties, was compared to those of ZR01, a reversible inhibitor of the same class and PD168393, a known irreversible inhibitor of EGFR. ZR20